Home

Morana Jovan-Embiricos

CIK 1575745 · last filed 2026-06-04

Morana Jovan-Embiricos is a corporate insider who has filed 23 SEC Form 4 insider transactions across 5 companies since 2014. The most recent filing, for KLRS, was dated Jun 4, 2026. Across all open-market trades the lifetime net is +$37.5M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $10.4M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$10.38M

Companies

5

Total Filings

23

Lifetime Open-Market Net

$37.47M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
KLRS Director — $4.19 — $0 2 2026-06-04
Kalaris Therapeutics, Inc. (ALVR) Delisted Director 42,081 $9.81 $412.8K $48.59M 11 2024-06-07
CGEM Director 578,214 $17.95 $10.38M -$10.70M 4 2022-06-28
TCR2 THERAPEUTICS INC. (TCRR) Delisted 10%+ Owner 90,026 $1.48 $133.2K -$412.5K 1 2019-10-24
Radius Health, Inc. (RDUS) Delisted Director 0 $30.00 $0 $0 5 2015-01-20

Recent Filings

23 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-04 KLRS Grant (A) — $0 EDGAR
2025-04-11 KLRS Grant (A) — $0 EDGAR
2024-06-07 Kalaris Therapeutics, Inc. (ALVR) Delisted Grant (A) +35,000 $0 EDGAR
2023-05-12 Kalaris Therapeutics, Inc. (ALVR) Delisted Grant (A) +35,000 $0 EDGAR
2022-08-01 Kalaris Therapeutics, Inc. (ALVR) Delisted Grant (A) +8,152,247 $37.58M EDGAR
2022-06-28 CGEM Mixed +95,296 $14 EDGAR
2022-06-23 CGEM Sell (S) −203,806 -$2.61M EDGAR
2022-05-19 Kalaris Therapeutics, Inc. (ALVR) Delisted Grant (A) — $0 EDGAR
2022-05-16 CGEM Sell (S) −837,476 -$8.09M EDGAR
2022-03-25 CGEM Grant (A) — $0 EDGAR
Showing 1–10 of 23
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.